Abstract
New evidence shows that patients with chronic kidney diseases are prone to develop thromboembolism. In this chapter, current knowledge of risk factors associated with thrombotic events, as well as practical approaches to anticoagulation in this population are discussed.
Keywords: Chronic kidney disease, thrombosis, anticoagulation, transplant.
Current Pediatric Reviews
Title:Chronic Kidney Disease and Thrombosis
Volume: 9 Issue: 3
Author(s): Steven Arora and Vladimir Belostotsky
Affiliation:
Keywords: Chronic kidney disease, thrombosis, anticoagulation, transplant.
Abstract: New evidence shows that patients with chronic kidney diseases are prone to develop thromboembolism. In this chapter, current knowledge of risk factors associated with thrombotic events, as well as practical approaches to anticoagulation in this population are discussed.
Export Options
About this article
Cite this article as:
Arora Steven and Belostotsky Vladimir, Chronic Kidney Disease and Thrombosis, Current Pediatric Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573396311309030004
DOI https://dx.doi.org/10.2174/1573396311309030004 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Antiplatelet Therapy in the Prevention of Coronary Syndromes: Mode of Action, Benefits, Drawbacks
Cardiovascular & Hematological Agents in Medicinal Chemistry Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery
Current Pharmaceutical Design L-Arginine Transport in Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches
Infectious Disorders - Drug Targets New Ways of Detecting ADRs in Neonates and Children
Current Pharmaceutical Design Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
Current Cancer Drug Targets Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Methylene Blue not Contraindicated in Treating Hemodynamic Instability in Pediatric and Neonate Patients
Current Pediatric Reviews Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives
Current Medicinal Chemistry Editorial (Thematic Issue: Biological Toxins and Medicinal Chemistry: Research and Therapeutic Tools)
Current Topics in Medicinal Chemistry Cardiovascular Therapeutics Targets on the NO–sGC–cGMP Signaling Pathway: A Critical Overview
Current Drug Targets Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets Therapeutic Macromolecular Iron Chelators
Current Medicinal Chemistry Atypical Antipsychotic Drugs During Pregnancy. Their Effects on the Mother and Offspring
Current Women`s Health Reviews